- Alternative therapy cardiology critical care Dermatology Endocrinology & Metabolism gastroenterology GI & liver harm HEENT Hematology hepatology HIV Hospital medicine ID immunology infection Nephrology Neurology Oncology ophthalmology Orthopaedics patient satisfaction pulmonary medicine renal Reproductive health Rheumatology Surgery Syncope Toxicology Urology vascular
Tag Archives: GI & liver
HBsAg levels at 6 months of LMV-ADV combination therapy can help predict treatment response. More potent treatments should be considered for cases positive for HBeAg, with high baseline HBV DNA and high HBsAg levels after 6 months treatment. Kim, Jeong … Continue reading
Note: Figures and table numbers appear above the figures and tables and taken from the following source. Woreta TA1, Alqahtani SA. Evaluation of abnormal liver tests. Med Clin North Am. 2014 Jan;98(1):1-16. Table 1. Categorization of liver diseases by pattern of elevation of liver … Continue reading
Thrombotic mechanism in inflammatory bowel disease patients is complex, multifactorial and not fully understood. Acquired risk factors for thrombosis, often present in inflammatory bowel disease patients, only partially explain increased thrombotic risk. No relevant association has been found regarding genetic … Continue reading
What is the relationship between Neutrophil gelatinase-associated lipocalin and hepatorenal syndrome?
The Bottom Line: This study included 64 patients with cirrhosis and 23 control subjects. Patients with type 1 and type 2 HRS had significantly higher plasma and urine NGAL levels compared with stable cirrhosis and control subjects. This study concluded … Continue reading